glp 1 receptor agonist examples Frontiers GLP-1 Receptor Agonists and Other

doi: 10.1016/S0140-6736(23)01200-X

Rev Physiol Biochem Pharmacol (2015) 169:4369

Iddon JL, Morgan DJ, Loveday C, Sahakian BJ, Pickard JD

Study limitations include presence of statistical heterogeneity in the meta-analyses for change in HbA 1c and body weight, assessment of risk of bias solely for the primary outcome, and generalisation of findings mainly to individuals who are overweight or obese and already on metformin-based background therapy

The introduction of generics, such as Glenmarks liraglutide biosimilar launched at dramatically lower prices, reflects the push toward affordability and broader access in a cost-conscious market

Regular follow-up appointments should be scheduled according to individual needs, typically every 3-6 months during the first year of GLP-1 therapy, with thyroid function testing as clinically indicated